The efficacy and feasibility of the repeated intraperitoneal Paclitaxel +systemic TS-1 and Paclitaxel for far advanced or recurrent gastric cancer: Phase I/II trial.
Phase of Trial: Phase I/II
Latest Information Update: 09 May 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use